Abstract: Using cutting-edge techniques such as next-generation sequencing and microarray technologies, CD Genomics can provide comprehensive genomic services to support many industries, institutes, and companies. Based on rich experience in targeted sequencing, CD Genomics has developed a Disease Panel platform for targeted sequencing of disease-related genes to help researchers with cancer diagnostics and analysis, pathogen detection, and pharmacogenomics testing. The Disease Panel provides one-stop solutions (including both services and reagents) for the study of a wide range of diseases, including cancer, inherited disease, and infection by using NGS panels or non-NGS panels, which facilitate numerous applications such as disease research, biomarker discovery, and targeted drug development. Summary: Using cutting-edge techniques such as next-generation sequencing and microarray technologies, CD Genomics can provide comprehensive genomic services to support many industries, institutes, and companies. References: https://www.cd-genomics.com/diseasepanel/custom-ngs-panel.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Cancer Panels for Your Cancer Research
A Gene Mutation Panel with Non-NGS Technologies
miRNA: Introduction, Profiling Methods, and Applications
Insight Into Tumor Heterogeneity Through NGS
Identify Mutations in the Tumor